comparemela.com

Page 2 - News Ratings For Hims Hers Health Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hims & Hers Health (NYSE:HIMS) PT Raised to $24 00

Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective hoisted by Canaccord Genuity Group from $20.00 to $24.00 in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. HIMS has been the topic of several other research reports. Leerink Partnrs reiterated […]

Citigroup Lowers Hims & Hers Health (NYSE:HIMS) to Neutral

Citigroup cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm currently has $20.00 target price on the stock, up from their prior target price of $16.00. A number of other research […]

Citigroup Downgrades Hims & Hers Health (NYSE:HIMS) to Neutral

Citigroup downgraded shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to a neutral rating in a report published on Wednesday, MarketBeat.com reports. Citigroup currently has $20.00 price target on the stock, up from their previous price target of $16.00. Several other equities analysts have also issued reports on HIMS. […]

Hims & Hers Health (NYSE:HIMS) Shares Gap Down Following Insider Selling

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price gapped down before the market opened on Wednesday following insider selling activity. The stock had previously closed at $17.56, but opened at $17.11. Hims & Hers Health shares last traded at $16.71, with a volume of 1,528,158 shares traded. Specifically, insider Soleil Boughton […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.